Vygon (UK)

Per-Encounter Medical Market to Hit $327.84 Billion, Globally, by 2030 at 16% CAGR: Coherent Market Insights

Retrieved on: 
Thursday, December 7, 2023
DNA, Conditional sentence, Patient, Segment, Prostate, Therapy, Diagnosis, Growth, Neurology, Hospital, Stroke, DNA synthesis, ChromeOS, Telehealth, Massive parallel sequencing, Ambulatory Surgery Center Association, Food, Prevalence, Cardinal Health, Catheter, Catalent, Suture, Drug development, NGS, Synthetic biology, SPECT, Syringe, Market, Bandage, Cardiology, Research, Biotechnology, Health information management, FDG, PET, Stent, Classification, EHR, De novo, Distribution, Countertop, Cardiovascular disease, TURP, Medication, COVID-19, Death, Splenic infarction, Oncology, Beauty salon, Health insurance, Medical imaging, Pharmaceutical industry, Medical device, Geography, Endocrinology, Application, Vygon (UK)

The Per-Encounter Medical Market is influenced by various factors that drive its growth and reshape its landscape.

Key Points: 
  • The Per-Encounter Medical Market is influenced by various factors that drive its growth and reshape its landscape.
  • Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/6386
    Another driver boosting the growth of the Per-Encounter Medical Market is the demand for personalized healthcare services.
  • Per-encounter medical services enable healthcare providers to deliver personalized care by facilitating a one-on-one relationship between the patient and the healthcare professional.
  • Read complete market research report," Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Region, and Segment Forecast 2023-2030 ", Published by Coherent Market Insights.

Per-Encounter Medical Market to Hit $327.84 Billion, Globally, by 2030 at 16% CAGR: Coherent Market Insights

Retrieved on: 
Thursday, December 7, 2023
DNA, Conditional sentence, Patient, Segment, Prostate, Therapy, Diagnosis, Growth, Neurology, Hospital, Stroke, DNA synthesis, ChromeOS, Telehealth, Massive parallel sequencing, Ambulatory Surgery Center Association, Food, Prevalence, Cardinal Health, Catheter, Catalent, Suture, Drug development, NGS, Synthetic biology, SPECT, Syringe, Market, Bandage, Cardiology, Research, Biotechnology, Health information management, FDG, PET, Stent, Classification, EHR, De novo, Distribution, Countertop, Cardiovascular disease, TURP, Medication, COVID-19, Death, Splenic infarction, Oncology, Beauty salon, Health insurance, Medical imaging, Pharmaceutical industry, Medical device, Geography, Endocrinology, Application, Vygon (UK)

The Per-Encounter Medical Market is influenced by various factors that drive its growth and reshape its landscape.

Key Points: 
  • The Per-Encounter Medical Market is influenced by various factors that drive its growth and reshape its landscape.
  • Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/6386
    Another driver boosting the growth of the Per-Encounter Medical Market is the demand for personalized healthcare services.
  • Per-encounter medical services enable healthcare providers to deliver personalized care by facilitating a one-on-one relationship between the patient and the healthcare professional.
  • Read complete market research report," Per-Encounter Medical Market, By Product Type, By Application, By Distribution Channel, By Region, and Segment Forecast 2023-2030 ", Published by Coherent Market Insights.

ivWatch Expands Global Footprint into the United Kingdom

Retrieved on: 
Wednesday, May 31, 2023
CE, Business development, University, Infusion, Vygon (UK), Medication, BD (company), NHS Resolution, United Nations Convention on Contracts for the International Sale of Goods, Patient, ICU Medical, NEWS, United Kingdom, Knowledge, Growth, University of Surrey, FDA, MHRA, Nursing, Management, Pharmaceutical industry, Health care

NEWPORT NEWS, Va., May 31, 2023 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today announces its expansion into the United Kingdom. This key market has a strong focus on improving IV therapy. The NHS Resolution has its sight set on changing the outcomes associated with IV extravasations. ivWatch's patient monitoring innovation perfectly aligns with the initiative to help protect patients from unpredictable IV complications with early IV infiltration and extravasation detection. As the only medical device in the world to detect infiltrations and extravasations at the earliest stages, the launch of ivWatch technology comes at the perfect time in the UK. ivWatch products are FDA cleared, have the CE mark, and are registered in the UK with the Medicines and Healthcare products Regulatory Agency (MHRA).

Key Points: 
  • Clinical Advocate Helen Stephens, Registered General Nurse, Joins ivWatch Leadership Team as Vice President of International Sales, EMEA
    NEWPORT NEWS, Va., May 31, 2023 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today announces its expansion into the United Kingdom.
  • ivWatch products are FDA cleared, have the CE mark, and are registered in the UK with the Medicines and Healthcare products Regulatory Agency (MHRA).
  • Stephens will provide a wealth of knowledge to drive growth in the EMEA region and select other global high-demand markets.
  • She will be located in the United Kingdom and lead the company's international expansion plans from Europe.

ivWatch Expands Global Footprint into the United Kingdom

Retrieved on: 
Wednesday, May 31, 2023
CE, Business development, University, Infusion, Vygon (UK), Medication, BD (company), NHS Resolution, United Nations Convention on Contracts for the International Sale of Goods, Patient, ICU Medical, NEWS, United Kingdom, Knowledge, Growth, University of Surrey, FDA, MHRA, Nursing, Management, Pharmaceutical industry, Health care

NEWPORT NEWS, Va., May 31, 2023 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today announces its expansion into the United Kingdom. This key market has a strong focus on improving IV therapy. The NHS Resolution has its sight set on changing the outcomes associated with IV extravasations. ivWatch's patient monitoring innovation perfectly aligns with the initiative to help protect patients from unpredictable IV complications with early IV infiltration and extravasation detection. As the only medical device in the world to detect infiltrations and extravasations at the earliest stages, the launch of ivWatch technology comes at the perfect time in the UK. ivWatch products are FDA cleared, have the CE mark, and are registered in the UK with the Medicines and Healthcare products Regulatory Agency (MHRA).

Key Points: 
  • Clinical Advocate Helen Stephens, Registered General Nurse, Joins ivWatch Leadership Team as Vice President of International Sales, EMEA
    NEWPORT NEWS, Va., May 31, 2023 /PRNewswire/ -- ivWatch, LLC, the IV safety company, today announces its expansion into the United Kingdom.
  • ivWatch products are FDA cleared, have the CE mark, and are registered in the UK with the Medicines and Healthcare products Regulatory Agency (MHRA).
  • Stephens will provide a wealth of knowledge to drive growth in the EMEA region and select other global high-demand markets.
  • She will be located in the United Kingdom and lead the company's international expansion plans from Europe.

Enteral Feeding Devices Market worth $5.2 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, February 3, 2023
Tubing (recreation), Administration, Health, NICU, House, Hospital, AmSafe, DSM-IV codes, Acquisition, Obesity, Patient, US FDA, Liver, Pressure, Infant, Diabetes, Mortality, Risk, Hypermetabolism, Fresenius (company), Malnutrition, Partnership, Growth, HEN, Ronald McDonald House Charities, Becton, Dickinson and Company headquarters, Prevalence, COVID-19, Charitable organization, Cancer, Nursing, Vygon (UK)

By type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables.

Key Points: 
  • By type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables.
  • In 2020, the oncology segment accounted for the largest share of the enteral feeding devices market, followed by gastrointestinal diseases, neurological disorders diabetes, hypermetabolism, and other applications.
  • By Region, the enteral feeding devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • ·  In March 2021, Applied Medical Technology, Inc. (US) launched its gastric-jejunal enteral feeding tube family (G-JETs) to include the low-profile micro-G-JET to meet the enteral nutrition needs of pediatric patients.

Enteral Feeding Devices Market worth $5.2 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, February 3, 2023
Tubing (recreation), Administration, Health, NICU, House, Hospital, AmSafe, DSM-IV codes, Acquisition, Obesity, Patient, US FDA, Liver, Pressure, Infant, Diabetes, Mortality, Risk, Hypermetabolism, Fresenius (company), Malnutrition, Partnership, Growth, HEN, Ronald McDonald House Charities, Becton, Dickinson and Company headquarters, Prevalence, COVID-19, Charitable organization, Cancer, Nursing, Vygon (UK)

By type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables.

Key Points: 
  • By type, the enteral feeding devices market is segmented into enteral feeding tubes, enteral feeding pumps, enteral syringes, administration sets, and consumables.
  • In 2020, the oncology segment accounted for the largest share of the enteral feeding devices market, followed by gastrointestinal diseases, neurological disorders diabetes, hypermetabolism, and other applications.
  • By Region, the enteral feeding devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
  • ·  In March 2021, Applied Medical Technology, Inc. (US) launched its gastric-jejunal enteral feeding tube family (G-JETs) to include the low-profile micro-G-JET to meet the enteral nutrition needs of pediatric patients.

Insights on the Endotracheal Tube Global Market to 2026 - Advantages of Endotracheal Intubation is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, October 15, 2021
Medical Devices, Health, Vygon (UK), Prevalence, Incidence, ET, Ageing, Growth, Medtronic, ICU, Population, Hospital, COPD, Health care, USD, ETS, Patient, Conditional sentence, Critical care, Asthma, Potassium titanyl phosphate, Profile, Ventilation, Shiley, Geriatrics, CO2, Intubation, Anesthesia, Ventilator-associated pneumonia, COVID-19, Antibiotics, Health insurance

The following factors are likely to contribute to the growth of the endotracheal tube market during the forecast period:

Key Points: 
  • The following factors are likely to contribute to the growth of the endotracheal tube market during the forecast period:
    The growing prevalence of chronic respiratory conditions and increase in critical care admissions are driving the global endotracheal tube market.
  • Healthcare settings and advancements of the coated endotracheal tube are contributing to the growth of the market.
  • North America dominates the global endotracheal tube market with a revenue share of 42.60% in 2020.
  • North America accounted for a share of 42.60% in the global endotracheal tube market in 2020.